Jonathan R. Whitfield
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Corrigendum: Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice.
Journal: Genes & development
Published: July 01, 2026
The leading role of MYC in DNA damage response: exploring opportunities for therapeutic inhibition.
Journal: Frontiers in cell and developmental biology
Published: October 16, 2025
Corrigendum: Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma.
Journal: Genes & development
Published: September 02, 2025
MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancer.
Journal: Cell reports
Published: June 18, 2025
MYC in cancer: from undruggable target to clinical trials.
Journal: Nature reviews. Drug discovery
Published: January 17, 2025
MYC-driven gliosis impairs neuron-glia communication in amyotrophic lateral sclerosis.
Journal: Brain : a journal of neurology
Published: December 16, 2024
MYC-driven gliosis impairs neuron-glia communication in amyotrophic lateral sclerosis.
Journal: Brain : a journal of neurology
Published: December 16, 2024
Editorial: MYC as a disease target beyond cancer.
Journal: Frontiers in cell and developmental biology
Published: July 19, 2024
Therapeutic implications of the interplay between interferons and ER in breast cancer.
Journal: Cytokine & growth factor reviews
Published: December 27, 2023
MYC: there is more to it than cancer.
Journal: Frontiers in cell and developmental biology
Published: November 22, 2023
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 03, 2023
MYC targeting by OMO-103 in solid tumors: a phase 1 trial.
Journal: Nature medicine
Published: February 07, 2023
Last Updated: 09/26/2026